-
3 Ways to Communicate Your Value to Trial Participants
Clinical Research News | Although we’re seeing an increasing trend of site networks and academic research centers insourcing technology solutions themselves, unless they’re offered an Adaptive Experience that lets them choose how they want to participate at every step of the trial, they aren’t given a choice about using the technology. Keeping technology top of mind is critically important for research solutions to succeed.
Sep 16, 2022
-
Mount Sinai Aims To Enroll One Million People In Genetic Sequencing Project
Clinical Research News | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.
Sep 15, 2022
-
Public More Protective Of Their Health Information Than Their Biospecimens
Clinical Research News | In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information.
Sep 14, 2022
-
IVDR Creating ‘Significant Challenges’ For Global Precision Medicine Trials
Clinical Research News | The impact of Europe’s In Vitro Diagnostic Medical Devices Regulation on global trials for precision medicine was shared at the recent Next Generation Dx Summit held in Washington, DC. IVDR is finally coming into force and creating “significant challenges” for pharmaceutical companies sponsoring studies involving biomarker testing on EU patient samples.
Sep 13, 2022
-
The Hospital’s Evolving Role in Complementing Clinical Trials
Clinical Research News | People of color comprise approximately 39 percent of the U.S. population but typically only represent 2 to 16 percent of trial patients. Unlocking the clinical data captured by hospitals and health systems may be the key to closing gaps in care.
Sep 9, 2022